-
Tammaryn Lashley, PhD
… underlying frontotemporal dementia and studying whether multiple mechanisms are associated with the different …
-
Gjalt W. Huisman, PhD
… previously led efforts at Codexis, where his team advanced multiple therapeutic enzyme candidates—several with FDA …
-
Yuval Itan, PhD
… association studies (PheWAS) in large biobanks across multiple human populations, as demonstrated in his recent …
-
Developing a Protein Quality Control Mechanism as a Novel Therapy for Parkinson’s Disease
… that accumulate in cells of the central nervous system. In healthy cells, protein misfolding and aggregation … or reversed by various protein quality control (PQC) systems. However, we lack a complete understanding of these systems, which hinders our ability to develop therapies for …
-
The anatomic basis of cardiac and cognitive changes in Parkinson's disease: A collaborative study with the Parkinson's Institute, Sunnyvale, CA (USA)
… Objective/Rationale: The heart, particularly the conduction system, is influenced by the parasympathetic and sympathetic nervous systems. Recently, early-occurring Parkinson’s … cardiac pathology fits into the neuropathological staging system for the brain published by our Frankfurt group in …
-
FDA Approves New Deep Brain Stimulation Device
June 16, 2015
… The Brio Neurostimulation System consists of a pacemaker-like device implanted in the … disease and essential tremor. The Brio Neurostimulation System from St. Jude Medical works in a similar way as the … device: Medtronic’s Activa Deep Brain Stimulation Therapy System, approved in 1997 for tremor and in 2002 for …